Defective suppression of Th2 cytokines by CD4+CD25+ regulatory T cells in birch allergies during birch pollen season

Clinical and Experimental Allergy

Volumn 34, Issue 9, 2004, Pages 1364-1372

  Grindebacke, H ^a   Wing, K ^a   Andersson, A C ^a   Suri Payer, E ^b   Rak, S ^a   Rudin, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Allergy; CD4+CD25+ regulatory T cells; Cytokines; Human; Suppression

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5; MONOCLONAL ANTIBODY CD3; THYMIDINE;

ADULT; ALLERGIC DISEASE; ANTIGEN FUNCTION; ANTIGEN PRESENTING CELL; ANTIGEN PURIFICATION; ARTICLE; CELL FRACTIONATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE DEFICIENCY; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; POLLEN ALLERGY; PRIORITY JOURNAL; SEASONAL VARIATION; T LYMPHOCYTE ACTIVATION;

ADULT; ALLERGENS; BETULA; CELL DIVISION; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PLANT PROTEINS; POLLEN; RECEPTORS, INTERLEUKIN-2; RESPIRATORY HYPERSENSITIVITY; RHINITIS, ALLERGIC, SEASONAL; SEASONS; TH2 CELLS;

EID: 4544256262     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02067.x     Document Type: Article

References (37)

1. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2:389-400.
2. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160:1212-8.
3. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
4. Baud O, Goulet O, Canioni D et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001; 344:1758-62.
5. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15:430-5.
6. Akbari O, Stock P, DeKruyff RH, Umetsu DT. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 2003; 15:627-33.
7. Epton MJ, Hales BJ, Thompson PJ, Thomas WR. T cell cytokine responses to outer membrane proteins of Haemophilus influenzae and the house dust mite allergens Der p 1 in allergic and non-allergic subjects. Clin Exp Allergy 2002; 32:1589-95.
8. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103:175-83.
9. high regulatory cells in human peripheral blood. J Immunol 2001; 167:1245-53.
10. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164:183-90.
11. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287-96.
12. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10:1969-80.
13. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193:1285-94.
14. + T cells with regulatory properties from human blood. J Exp Med 2001; 193:1303-10.
15. + regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003; 171:5760-8.
16. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001; 194:629-44.
17. + regulatory T cell activity in both humans and mice. J Immunol 2004; 172:834-42.
18. R cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197:111-9.
19. + regulatory T cells. Eur J Immunol 2002; 32:1621-30.
20. + regulatory T cells are not functionally impaired in adult patients with IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2002; 110:934-6.
21. + T cells. Eur J Immunol 2003; 33:579-87.
22. + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol 2003; 170:394-9.
23. George TC, Bilsborough J, Viney JL, Norment AM. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro. Eur J Immunol 2003; 33:502-11.
24. H2 cytokine production. J Allergy Clin Immunol 2003; 111:862-8.
25. + T cells in thymus, cord and adult blood. Immunology 2002; 106:190-9.
26. Karlsson H, Hessle C, Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun 2002; 70:6688-96.
27. Kukreja A, Cost G, Marker J et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002; 109:131-40.
28. + T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003; 33:215-23.
29. + regulatory thymocytes because of their responsiveness to different cytokines. Blood 2004; 103:3117-21.
30. + t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193:1295-302.
31. + cells: a naturally occurring population of regulatory T cells. Blood 2001; 98:2736-44.
32. + T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001; 31:1122-31.
33. - T cells. J. Clin. Invest 2003; 112:1437-43.
34. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002; 196:1335-46.
35. + T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003; 111:1255-61.
36. Jutel M, Akdis M, Budak F et al. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33:1205-14.
37. Hart TK, Blackburn MN, Brigham-Burke M et al. Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin Exp Immunol 2002; 130:93-100.